CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Carl Zeiss Meditec AG - AFX CFD

    127.18
    1.84%
    0.54
    Low: 124.54
    High: 127.78
    Market Trading Hours* (UTC) Opens on Monday at 07:00

    Mon - Fri: 07:00 - 15:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.54
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.019277 %
    Charges from borrowed part ($-0.77)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.019277%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.002946 %
    Charges from borrowed part ($-0.12)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.002946%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 20%
    Stock exchange Germany
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 124.88
    Open* 125.28
    1-Year Change* -16.14%
    Day's Range* 124.54 - 127.78
    52 wk Range 101.75-152.20
    Average Volume (10 days) 139.60K
    Average Volume (3 months) 2.08M
    Market Cap 11.45B
    P/E Ratio 37.38
    Shares Outstanding 89.44M
    Revenue 1.96B
    EPS 3.42
    Dividend (Yield %) 0.85938
    Beta 0.66
    Next Earnings Date May 9, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 31, 2023 127.18 2.30 1.84% 124.88 127.88 124.29
    Mar 30, 2023 124.88 4.54 3.77% 120.34 125.18 120.34
    Mar 29, 2023 122.99 -4.84 -3.79% 127.83 128.63 122.89
    Mar 28, 2023 126.83 -8.14 -6.03% 134.97 135.52 126.83
    Mar 27, 2023 134.47 1.70 1.28% 132.77 135.87 132.77
    Mar 24, 2023 132.22 -3.90 -2.87% 136.12 136.17 131.77
    Mar 23, 2023 134.77 3.85 2.94% 130.92 134.77 130.87
    Mar 22, 2023 132.02 0.35 0.27% 131.67 133.82 131.02
    Mar 21, 2023 131.27 -3.80 -2.81% 135.07 135.17 127.33
    Mar 20, 2023 134.47 -2.25 -1.65% 136.72 138.66 134.37
    Mar 17, 2023 137.51 0.20 0.15% 137.31 138.11 136.07
    Mar 16, 2023 136.92 0.45 0.33% 136.47 137.07 132.67
    Mar 15, 2023 135.07 -2.94 -2.13% 138.01 138.21 133.07
    Mar 14, 2023 138.06 2.24 1.65% 135.82 140.16 135.62
    Mar 13, 2023 135.77 0.30 0.22% 135.47 136.32 132.47
    Mar 10, 2023 135.47 1.15 0.86% 134.32 136.07 134.17
    Mar 9, 2023 136.37 3.65 2.75% 132.72 136.52 132.22
    Mar 8, 2023 133.27 -0.20 -0.15% 133.47 134.42 132.32
    Mar 7, 2023 134.82 -1.85 -1.35% 136.67 137.41 134.32
    Mar 6, 2023 133.62 0.25 0.19% 133.37 134.12 132.47

    Carl Zeiss Meditec AG Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1902.84 1646.79 1335.45 1459.32 1280.86
    Revenue 1902.84 1646.79 1335.45 1459.32 1280.86
    Cost of Revenue, Total 775.238 679.572 589.935 627.437 570.471
    Gross Profit 1127.6 967.213 745.517 831.884 710.389
    Total Operating Expense 1505.96 1273.17 1157.9 1194.66 1083.73
    Selling/General/Admin. Expenses, Total 438.06 363.98 349.161 393.913 353.646
    Research & Development 291.365 232.066 218.804 173.312 159.628
    Operating Income 396.879 373.614 177.552 264.659 197.13
    Interest Income (Expense), Net Non-Operating -44.479 -32.12 -21.351 -34.497 -20.449
    Other, Net 51.089 -2.444 22.516 -0.304 2.502
    Net Income Before Taxes 403.489 339.05 178.717 229.858 179.183
    Net Income After Taxes 295.911 237.519 123.421 160.579 126.23
    Minority Interest -2.002 -1.243 -1.036 -0.823 0.233
    Net Income Before Extra. Items 293.909 236.276 122.385 159.756 126.463
    Net Income 293.909 236.276 122.385 159.756 126.463
    Income Available to Common Excl. Extra. Items 293.909 236.276 122.385 159.756 126.463
    Income Available to Common Incl. Extra. Items 293.909 236.276 122.385 159.756 126.463
    Diluted Net Income 293.909 236.276 122.385 159.756 126.463
    Diluted Weighted Average Shares 89.4406 89.4406 89.4406 89.4406 89.4406
    Diluted EPS Excluding Extraordinary Items 3.28608 2.64171 1.36834 1.78617 1.41393
    Dividends per Share - Common Stock Primary Issue 1.1 0.9 0.5 0.65 0.55
    Diluted Normalized EPS 3.28608 2.62254 1.41621 1.826 1.44229
    Unusual Expense (Income) -2.447 0
    Other Operating Expenses, Total 1.294 0 -0.015
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 470.3 569.936 477.495 445.229 410.176
    Revenue 470.3 569.936 477.495 445.229 410.176
    Cost of Revenue, Total 212.9 227.538 193.645 176.654 177.401
    Gross Profit 257.4 342.398 283.85 268.575 232.775
    Total Operating Expense 410 448.957 378.919 342.273 335.808
    Selling/General/Admin. Expenses, Total 116.1 133.26 111.092 95.837 97.871
    Research & Development 81 87.165 73.972 69.692 60.536
    Unusual Expense (Income)
    Operating Income 60.3 120.979 98.576 102.956 74.368
    Interest Income (Expense), Net Non-Operating 11.7 -2.679 -12.957 -8.662 -20.181
    Other, Net 1 22.689 2.71 25.805 -0.115
    Net Income Before Taxes 73 140.989 88.329 120.099 54.072
    Net Income After Taxes 50.5 103.811 61.996 92.095 38.009
    Minority Interest 0.5 -1.102 0.536 -1.367 -0.069
    Net Income Before Extra. Items 51 102.709 62.532 90.728 37.94
    Net Income 51 102.709 62.532 90.728 37.94
    Income Available to Common Excl. Extra. Items 51 102.709 62.532 90.728 37.94
    Income Available to Common Incl. Extra. Items 51 102.709 62.532 90.728 37.94
    Diluted Net Income 51 102.709 62.532 90.728 37.94
    Diluted Weighted Average Shares 89.4737 89.7249 89.3318 89.8297 89.5912
    Diluted EPS Excluding Extraordinary Items 0.57 1.14471 0.7 1.01 0.42348
    Dividends per Share - Common Stock Primary Issue 0 1.1 0 0 0
    Diluted Normalized EPS 0.59165 1.14471 0.7 1.01 0.42348
    Other Operating Expenses, Total 0 0.994 0.21 0.09 0
    Total Adjustments to Net Income 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 1604.02 1290.51 1304.33 1251.06 1207.89
    Cash and Short Term Investments 7.439 6.202 22.639 7.843 8.315
    Cash 7.439 6.202 22.639 6.678 3.925
    Cash & Equivalents
    Total Receivables, Net 1294.65 979.93 1000.34 981.046 935.904
    Accounts Receivable - Trade, Net 185.94 165.158 205.789 192.33 195.256
    Total Inventory 286.375 286.36 268.322 248.092 234.303
    Prepaid Expenses 9.502 8.144 10.759 9.352 9.986
    Other Current Assets, Total 6.049 9.871 2.266 4.723 19.38
    Total Assets 2395.97 2014.85 2022.13 1662.05 1623.11
    Property/Plant/Equipment, Total - Net 199.555 135.265 116.752 62.632 58.696
    Property/Plant/Equipment, Total - Gross 379.88 320.308 280.47 196.305 174.346
    Accumulated Depreciation, Total -180.325 -185.043 -163.718 -133.673 -115.65
    Goodwill, Net 328.714 326.51 338.094 185.638 174.313
    Intangibles, Net 153.698 145.221 144.336 74.087 68.491
    Long Term Investments 6.713 4.108 5.173 0.122 19.3
    Note Receivable - Long Term 9.191 9.225 10.961 9.29 14.565
    Other Long Term Assets, Total 94.079 104.014 102.484 79.227 79.855
    Total Current Liabilities 448.118 297.584 339.6 280.18 316.078
    Accounts Payable 145.465 91.679 118.12 101.437 100.463
    Accrued Expenses 137.816 109.294 115.657 98.181 80.259
    Notes Payable/Short Term Debt 0.645 0.209 0.192 15.71 5.733
    Current Port. of LT Debt/Capital Leases 19.341 15.512 14.661 3.529 2.819
    Other Current Liabilities, Total 144.851 80.89 90.97 61.323 126.804
    Total Liabilities 736.641 583.133 623.69 368.588 407.731
    Total Long Term Debt 178.425 140.636 151.837 7.321 3.588
    Long Term Debt 76.496 87.543 109.009 0 0.593
    Capital Lease Obligations 101.929 53.093 42.828 7.321 2.995
    Deferred Income Tax 15.438 17.166 18.198 5.234 8.918
    Minority Interest 18.056 18.841 18.517 21.17 26.358
    Other Liabilities, Total 76.604 108.906 95.538 54.683 52.789
    Total Equity 1659.33 1431.72 1398.44 1293.46 1215.38
    Common Stock 89.441 89.441 89.441 89.441 89.441
    Additional Paid-In Capital 620.137 620.137 620.137 620.137 620.137
    Retained Earnings (Accumulated Deficit) 1000.48 808.922 744.673 632.486 555.215
    Other Equity, Total -50.729 -86.783 -55.812 -48.6 -49.416
    Total Liabilities & Shareholders’ Equity 2395.97 2014.85 2022.13 1662.05 1623.11
    Total Common Shares Outstanding 89.4406 89.4406 89.4406 89.4406 89.4406
    Short Term Investments 0 1.165 4.39
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 1674.57 1604.02 1451.74
    Cash and Short Term Investments 21.589 17.918 17.352
    Cash & Equivalents 8.401 7.439 8.315
    Short Term Investments 13.188 10.479 9.037
    Total Receivables, Net 1298.01 1274.3 1140.1
    Accounts Receivable - Trade, Net 156.475 185.94 164.928
    Total Inventory 328.867 286.375 274.078
    Other Current Assets, Total 26.105 25.422 20.211
    Total Assets 2526.01 2395.97 2217.7
    Property/Plant/Equipment, Total - Net 205.703 199.555 189.302
    Goodwill, Net 379.934 328.714 323.349
    Intangibles, Net 163.484 153.698 144.045
    Long Term Investments 6.843 6.713 4.843
    Note Receivable - Long Term 9.096 9.191 8.339
    Other Long Term Assets, Total 86.374 94.079 96.077
    Total Current Liabilities 499.258 448.118 347.866
    Accounts Payable 140.474 145.465 123.336
    Accrued Expenses 109.277 127.787 92.307
    Notes Payable/Short Term Debt 0 0 0
    Current Port. of LT Debt/Capital Leases 18.97 19.341 17.876
    Other Current Liabilities, Total 230.537 155.525 114.347
    Total Liabilities 788.612 736.641 672.152
    Total Long Term Debt 189.666 178.425 192.216
    Long Term Debt 88.588 76.496 90.194
    Capital Lease Obligations 101.078 101.929 102.022
    Deferred Income Tax 15.035 15.438 16.932
    Minority Interest 18.693 18.056 17.705
    Other Liabilities, Total 65.96 76.604 97.433
    Total Equity 1737.39 1659.33 1545.55
    Common Stock 89.441 89.441 89.441
    Additional Paid-In Capital 620.137 620.137 620.137
    Retained Earnings (Accumulated Deficit) 1048.65 1000.48 909.534
    Other Equity, Total -20.833 -50.729 -73.565
    Total Liabilities & Shareholders’ Equity 2526.01 2395.97 2217.7
    Total Common Shares Outstanding 89.4406 89.4406 89.4406
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line 237.519 123.421 160.579 126.23 135.778
    Cash From Operating Activities 362.663 178.527 219.634 187.207 37.732
    Cash From Operating Activities 61.584 60.425 48.37 31.282 24.235
    Non-Cash Items 110.074 58.691 76.373 54.526 47.269
    Cash Taxes Paid 97.908 58.964 65.07 48.364 54.73
    Cash Interest Paid 1.629 1.365 1.903 1.94 1.559
    Changes in Working Capital -46.514 -64.01 -65.688 -24.831 -169.55
    Cash From Investing Activities -75.2 -70.947 -145.846 -28.874 -55.931
    Capital Expenditures -66.101 -44.986 -46.711 -34.756 -39.022
    Other Investing Cash Flow Items, Total -9.099 -25.961 -99.135 5.882 -16.909
    Cash From Financing Activities -285.889 -122.961 -58.637 -157.237 14.494
    Financing Cash Flow Items -223.862 -48.775 4.321 -104.529 -259.854
    Total Cash Dividends Paid -44.72 -58.136 -49.192 -49.192 -37.565
    Issuance (Retirement) of Debt, Net -17.307 -16.05 -13.766 -3.516 -3.123
    Foreign Exchange Effects -0.337 -1.056 0.81 1.657 -1.08
    Net Change in Cash 1.237 -16.437 15.961 2.753 -4.785
    Issuance (Retirement) of Stock, Net 0 315.036
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line 130.104 101.501
    Cash From Operating Activities 74.484 151.878
    Cash From Operating Activities 33.045 29.924
    Non-Cash Items 16.671 44.673
    Cash Taxes Paid 61.722 41.015
    Cash Interest Paid 0.679 0.67
    Changes in Working Capital -105.336 -24.22
    Cash From Investing Activities -54.311 -28.769
    Capital Expenditures -35.335 -23.26
    Other Investing Cash Flow Items, Total -18.976 -5.509
    Cash From Financing Activities -18.33 -124.663
    Financing Cash Flow Items -9.441 -116.396
    Issuance (Retirement) of Debt, Net -8.889 -8.267
    Foreign Exchange Effects -0.881 -0.31
    Net Change in Cash 0.962 2.113
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Carl Zeiss Group Corporation 59.14 52895153 35776 2022-11-15
    Capital Research Global Investors Investment Advisor 4.9912 4464153 -46868 2023-02-13 LOW
    Capital World Investors Investment Advisor 1.6403 1467117 0 2023-01-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1483 1027089 1286 2023-02-28 LOW
    Invesco Advisers, Inc. Investment Advisor 0.8941 799668 -11471 2023-01-31 LOW
    Groupama Asset Management Investment Advisor 0.8665 775034 -37628 2022-09-30 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 0.7616 681161 27 2023-02-28 LOW
    BlackRock Asset Management Deutschland AG Investment Advisor 0.7572 677231 -8165 2023-02-28 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7343 656754 -13903 2023-02-28 LOW
    Allianz Global Investors GmbH Investment Advisor 0.6845 612201 -1744 2023-02-28 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.5952 532334 153016 2023-02-28 HIGH
    Candriam Luxembourg S.A. Investment Advisor 0.5894 527175 -10543 2023-01-31 HIGH
    La Financière de l'Echiquier Investment Advisor 0.5405 483394 -6 2022-11-30 LOW
    Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.4626 413722 -16606 2023-01-31 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.442 395285 17110 2023-02-28 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.4095 366292 -451602 2022-12-31 LOW
    Deka Investment GmbH Investment Advisor/Hedge Fund 0.332 296921 -10699 2023-02-28 LOW
    Credit Mutuel Asset Management Investment Advisor 0.2971 265728 250534 2022-12-31 HIGH
    Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 0.2487 222410 -1214 2022-11-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.2357 210844 1186 2023-01-31 LOW

    Start a global, multi-asset portfolio with an award-winning platform

    Trade now Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Carl Zeiss Meditec Company profile

    About Carl Zeiss Meditec AG

    Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

    Financial summary

    BRIEF: For the three months ended 31 December 2021, Carl Zeiss Meditec AG revenues increased 11% to EUR410.2M. Net income decreased 18% to EUR37.9M. Revenues reflect Ophthalmic Devices segment increase of 10% to EUR310.9M, Microsurgery segment increase of 16% to EUR99.3M, Asia/Pacific Region segment increase of 15% to EUR181.5M, EMEA segment increase of 5% to EUR114.1M.

    Equity composition

    10/2006, Rights Issue, 3 new shares for every 2 shares held @ EUR 10.1 (Factor: 1.369066).

    Industry: Advanced Medical Equipment & Technology (NEC)

    Göschwitzer Straße 51-52
    JENA
    THUERINGEN 07745
    DE

    Income Statement

    • Annual
    • Quarterly

    News

    A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

    PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

    Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

    09:37, 31 March 2023
    People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

    Singapore's DBS has seen inflows in SVB aftermath, CEO says

    DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

    09:24, 31 March 2023
    Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

    US STOCKS-Futures muted as investors await key inflation data

    U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

    09:16, 31 March 2023
    A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

    Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

    Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

    09:14, 31 March 2023
    A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

    Coal India surpasses annual output target for first time in 17 years

    Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

    09:13, 31 March 2023
    A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

    Global IPOs marred by banks and recession enjoy few bright spots

    A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

    09:06, 31 March 2023
    A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

    UniCredit shareholders gather to vote on CEO's new pay scheme

    Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

    09:04, 31 March 2023

    People also watch

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Long position overnight fee -0.0185%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    BTC/USD

    28,466.00 Price
    +0.180% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 60.00

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Long position overnight fee -0.0156%
    Short position overnight fee -0.0063%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Long position overnight fee -0.0249%
    Short position overnight fee 0.0027%
    Overnight fee time 21:00 (UTC)
    Spread 3.0

    Still looking for a broker you can trust?

    Join the 500.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading